SASarah Magdy Abdelhamid

Sarah Magdy Abdelhamid

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sarah Magdy Abdelhamid has a total of 37 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Study of some potential biomarkers in Egyptian hepatitis C virus patients in relation to liver disease progression and HCC

    by Kholoud Baraka, Rania R. Abozahra, Eman Badr, Sarah M. Abdelhamid

    Background: Egypt has the greatest prevalence of hepatitis C worldwide according to the WHO reports, accounting for 13% of the global HCV infections. HCV is a substantial precursor for fibrosis, cirrhosis, and hepatocellular carcinoma. This study aimed to investigate the potential relevance of some cytokines, miR-122 and miR-221 for the diagnosis of liver disease progression associated to HCV infection. Methods: One hundred and twenty blood samples were collected from patients with chronic liver disease, HCC, and healthy individuals. Total bilirubin, alanine aminotransferase, aspartate aminotransferase, platelet count, albumin, and creatinine were measured. Serum level of selected cytokines was conducted by ELISA. Serum miRNA expression was detected by RT-PCR. Results: IL-2R was higher among HCC patients and the mean concentration of both TNF-αRII and IL-6R was higher among cirrhotic patients. The expression of miRNA-122 showed a little fold decrease in all studied groups; the highest level was observed in HCC patients. The expression of miRNA-221 showed a significant fold increase in HCC and cirrhotic groups. Conclusions: This study revealed that there is no difference in liver disease progression in patients regarding sex and age. Routine liver function tests performed poorly in terms of early diagnosis of liver disease progression; however, serum total bilirubin gave somewhat useful guide for discrimination between fibrotic, cirrhotic and HCC cases. IL-2R showed a significant consistent increase in its level with disease progression. The miR-221 serum level showed significant fold increase with liver disease progression. Therefore, making miR-221 a potential non-invasive biomarker for liver disease progression in the diagnostic setting is recommended.


  • Open Access

    Interspecies Interaction between Pseudomonas aeruginosa, Staphylococcus aureus and E. coli in vitro

    by Ibrahim A. Abdelwahab, Rania R. Abozahra, Shawky A. Sultan, Hala M. Abd-Elaal, Sarah M. Abdelhamid

  • Open Access

    Investigation of the protective and therapeutic effects of Lactobacillus casei and Saccharomyces cerevisiae in a breast cancer mouse model

    by Kholoud Baraka, Rania Abozahra, Maged Wasfy Helmy, Nada Salah El Dine El Meniawy, Sarah M Abdelhamid

    Introduction The development of novel strategies for cancer therapy is crucial to improve standard treatment protocols. Aim This study aimed to determine the protective and therapeutic effects of heat-killed preparations of Lactobacillus casei and Saccharomyces cerevisiae in a breast cancer mouse model. Methods Forty-two female BALB/c mice (7–8 weeks old) were divided into six groups (seven mice per group). Four groups were injected with 107 Ehrlich ascites tumor (EAT) cells suspended in phosphate-buffered saline (PBS) subcutaneously into the left side of the mammary fat pad. Tumor growth was monitored weekly until all animals developed a palpable tumor. The tumor-bearing mice in the experimental groups received heat-killed L. casei or S. cerevisiae three times per week for 35 days. The mice in the control group received PBS. The remaining two groups received heated L. casei or S. cerevisiae and then were injected with EAT cells. After 35 days, all mice were sacrificed to determine the immune response. Results Animals that received heated S. cerevisiae exhibited the lowest rate of tumor growth compared with the other groups. TGF-β and IL-4 secretion was increased in all mice, whereas the secretion of INF-γ and IL-10 was decreased in breast tissues. Moreover, at the histopathological level, the volume of viable tumor in the control group was higher than in the treated groups. Conclusion Supplementary treatment with S. cerevisiae resulted in the best outcome in the breast cancer model compared with other treated and vaccinated groups.


  • Open Access

    Identifying Different Mutation Sites Leading to Resistance to the Direct-Acting Antiviral (DAA) Sofosbuvir in Hepatitis C Virus Patients from Egypt

    by Aly Atef Shoun, Rania Abozahra, Kholoud Baraka, Mai Mehrez, Sarah M. Abdelhamid

    The hepatitis C virus (HCV) is a major global health challenge and a leading cause of morbidity and mortality. Many direct-acting antivirals (DAAs) target essential macromolecules involved in the virus’ life cycle. Although such DAAs achieve great success in reducing the viral load in genotype 1 infections, other genotypes demonstrate different levels of response. This study focused on mutation sites associated with patients with genotype 4a infections that failed to respond to treatment with sofosbuvir. The genotyping of HCV samples from patients with virological failure, and responder patients, was conducted using Geno2Pheno webserver-based full NS5B sequences. We constructed 3D structural models for all the samples and used structural analysis to investigate the effect of amino acid substitution on the observed resistance to SOF-based treatment, and the docking of sofosbuvir into the active sites of the 10 models was performed. Finally, 10 molecular dynamic (MD) simulation experiments were conducted to compare the stability of the 3D models of the resistant samples against the stability of the 3D models of the responder samples. The results highlighted the presence of HCV subtype 4a in all ten samples; in addition, an amino acid (aa) substitution in the palm region may hinder HCV polymerase activity. In this study, we provide evidence that a mutation in the NS5B gene that induces resistance to sofosbuvir in patients with the S282T/C/R mutant virus is present in the Egyptian population. Overall, the docking and MD results support our findings and highlight the significant impact of the identified mutations on the resistance of HCV NS5B RNA-dependent RNA polymerase to direct-acting antivirals (DAAs).


  • Open Access

    Genotyping and Molecular Characterization of Carbapenem-resistant Acinetobacter baumannii Strains Isolated from Intensive Care Unit Patients

    by Rania Abozahra, Sarah M. Abdelhamid, Amel G. Elsheredy, Kawther E. Abdulwahab, Kholoud Baraka

    Rania Abozahra*, Sarah M. Abdelhamid, Amel G. Elsheredy, Kawther E. Abdulwahab, and Kholoud Baraka. Microbiol. Biotechnol. Lett. 2021;49:1-10. https://doi.org/10.48022/mbl.2008.08012


  • Open Access

    Genotyping and Virulence Analysis of Drug Resistant Clinical Klebsiella pneumoniae Isolates in Egypt

    by Sarah M. Abdelhamid, Hala Mohamed Abd-Elaal, Moustafa Osama Matareed, Kholoud Baraka

    Klebsiella pneumoniae is a highly drug-resistant human pathogen responsible for a variety of serious infections. Integrons, mobile genetic elements capable of integrating antibiotic resistance genes, and the capsule are important virulence factors that increase bacteria resistance to phagocytosis and antimicrobial agents. Molecular typing is an effective tool for identifying the likely etiology of infection. This study aimed to investigate the presence of the rmpA, wcaG, intI1, intI2, and intI3 virulence genes in clinical Klebsiella pneumoniae isolates, and explore their molecular genotypes by using ERIC-PCR. Fifty Klebsiella pneumoniae strains were isolated from various specimens. Antimicrobial resistance was evaluated by using the disc diffusion method. Five genes were amplified by conventional PCR. Genotyping was performed molecularly by using ERIC-PCR. Forty-seven isolates were multi-drug resistant. In all, 18%, 36%, and 98% of the 50 K. pneumoniae isolates were positive for rmpA, wcaG, and intI1 genes, respectively; however, all isolates were negative for intI2 and intI3 genes. Dendogram analysis of the ERIC-PCR results showed 49 distinct patterns, arranged in five clusters. Our study demonstrates high levels of antibiotic resistance and virulence among clinical isolates of K. pneumoniae. Such resistance reflects a growing problem for public health. Further, the presence of integrons increases the horizontal spread of antibiotic resistance and virulence genes among bacterial isolates. The ERIC-PCR technique is an effective method for molecular typing and epidemiological studies of hospital-acquired infections.


  • Open Access

    Detection and phylogenetic analysis of Human bocavirus in children diagnosed with acute respiratory tract infection

    by Rania Abozahra, Sarah M. Abdelhamid, Karim Khairy, Kholoud Baraka

    Introduction.Human bocavirus (HBoV) is a recently discovered parvovirus; it has been shown to be a common cause of respiratory infections and gastroenteritis in children. Since its identification, HBoV has been detected worldwide in nasopharyngeal swabs, serum and stool samples particularly those obtained from young children suffering from respiratory or gastrointestinal tract infections.Aim.The aim of this work was to determine HBoV prevalence among children with acute respiratory tract infection in Egypt, to detect the most prevalent HBoV genotype and to compare PCR and ELISA as diagnostic techniques for HBoV infection.Methods.Nasopharyngeal swabs and blood samples were obtained within the first day of admission from 75 children diagnosed with acute respiratory tract infection in El-Shatby University Hospital for Children in Alexandria, Egypt from October 2018 to March 2019. Conventional PCR was used to detect HBoV DNA, ELISA was used to detect HBoV IgM antibodies and sequencing of the VP1/2 genes was used for genotyping.Results.Seven (9.3%) of the 75 nasopharyngeal swabs obtained from patients with acute respiratory tract infection were positive for HBoV by PCR, while 5 (6.7 %) of the 75 serum samples were positive for HBoV IgM antibodies using ELISA. The correlation between PCR and ELISA results showed a highly significant association between PCR and ELISA techniques (X2=52.041,PPConclusion.Human bocaviruswas detected at 9.3 % prevalence in nasopharyngeal swabs obtained from children with acute respiratory tract infection. The HBoV-1 genotype was the only genotype detected, suggesting that a single genetic lineage of HBoV is circulating in Egypt. PCR and ELISA are two reliable methods for detection and diagnosis of HBoV.


  • SYNTHESIS AND CHARACTERIZATION OF METALLIC AND POLYMERIC NANOPARTICLES AND THEIR EFFECT ON THE ANTIBACTERIAL PROPERTIES OF MICROHYBRID COMPOSITE RESIN

    by Mona M. Abdelrehim, Mona H. Mohy El Din, Sonia M. El-Shabrawy, Amal E. Fahmy, Sarah M. Abdelhamid, Heba S. Ramadan

    INTRODUCTION: During the past decade, composites have become the most commonly used restorative materials. The rate of dental caries following treatment with composite resin is high. Therefore, one of the most applicable methods for preventing enamel demineralization around the restorations is using dental materials resistant to the bacterial accumulation OBJECTIVES: To synthesis and characterize antibacterial nanoparticles and to evaluate the effect of blending microhybrid composite with zinc oxide nanoparticles (ZnO), Chitosan (Cs) and combination of both Chitosan/Zinc oxide nanoparticles (Cs/ZnO) and properties of these nanoparticles on the composite resin. MATERIALS AND METHODS: Three antibacterial nanoparticles were prepared and characterized in terms of particle size, zeta potential, shape, morphology and functional group determination. Minimum inhibitory concentration of the nanoparticles was determined. The nanoparticles were incorporated into commercial microhybrid composite resin. The antibacterial properties against Streptococcus mutans were evaluated by disc diffusion test and direct contact test. The results were analyzed using ANOVA test at p ≤ .05 significance level. RESULTS: For agar diffusion disc, incorporation of ZnO nanoparticles into the composite resin results in an antibacterial effect which lasted for up to 12 weeks, while for the Cs and Cs/ZnO nanoparticles the antibacterial effect lasted for up to 2 weeks. The direct contact test visualized under SEM also showed that incorporation of ZnO nanoparticles into composite resin to be the most inhibitory in all the 4 groups, denoting that ZnO-NPs has a far better inhibitory effect than Cs-NPs and Cs/ ZnO-NPs. CONCLUSIONS Antibacterial nanoparticles could be synthesized and characterized by Zetasizer NanoZS, scanning electron, transmission microscopy and Fourier transform infrared spectroscopy. Incorporation of ZnO, Cs and Cs/ZnO nanoparticles into the composite resin could significantly inhibit the S. mutans. The antimicrobial efficacy of the ZnO nanoparticles blended with microhybrid composite resin was confirmed for a duration up to 12 weeks


  • Open Access

    Validation of GeneXpert MRSA/SA Blood Culture Assay in Patients with Suspected Bacteremia

    by Sarah M. Abdelhamid

    Background: The GeneXpert MRSA/SA Blood Culture (BC) assay was validated prospectively in patients with suspected bacteremia. Objectives: The purpose of this study was to compare the Xpert MRSA/SA Blood Culture Assay to conventional culturing techniques. Methodology: Positive blood cultures flagged up by the BacT/ALERT® 3D system were gram stained and subcultured. Results: Out of the 33, 28 (84.8%) were identified as CoNs by phenotypic methods. The remaining 5 were identified as S aureus. GeneXpert results were concordant with the phenotypic results in 30 (90.9%) of samples. Twenty two of the CoNs were methicillin-resistant isolates and five were methicillin-sensitive isolates. Of the 5 S aureus , 3 were concordant. One MRSA and two MSSA. This result is statistically significant at p < .05. The mean time to notification of Xpert BC assay results was 1.5 hours. Conclusion: The Xpert assay is dependable, fast and reproducible for on-demand testing in health care settings where such testing is needed.

  • Open Access

    Comparison of the diagnostic utility of ADA and CA125 in tuberculous effusion

    by M.S. El Hoshy, A.A. Abdallah, S.M. Abd Elhamid

    BackgroundPleural effusion can be due to various pleural infections like TB as well as neoplasia. CA125 is a tumor marker found on the surface of ovarian and other normal cells as pleural cells. CA125 has been found to increase in serum and hence pleural fluid of patients with pleural effusion due to malignancy as well as due to TB.This study was conducted to evaluate the utility of CA125 in the diagnosis of pleural effusion resulting from TB, malignancy and pneumonia as well as to evaluate and compare the diagnostic utility of CA125 and ADA in the diagnosis of TB effusion.Patients and methods20 patients with tuberculous effusion (group I), 20 patients with malignant effusion (group II) and 20 patients with parapneumonic effusions (group III) were evaluated for the levels of CA125 and ADA in their pleural fluid. In malignant cases, diagnosis was made through microscopic inspection of pleural biopsy samples and cytology of pleural fluid. For diagnosis of tuberculosis, Ziehl Neelsen sputum smear, pleural fluid smear and/ or culture. Parapneumonic effusions were confirmed by pleural fluid cell count and culture & sensitivity.ResultsThe mean±SD level of CA125 in pleural fluid was 41.732±20.744U/ml, 309.27±79.564U/ml and 7.040±5.601U/ml in tuberculous, malignant and parapneumonic effusions respectively; which showed a statistically significant difference between the three groups (p<0.01). Pleural fluid CA125 was significantly higher in group II than group I (P1=0.000), and group III (P3=0.000). Pleural fluid CA125 was significantly higher in group I than group III (P2=0.000). Pleural fluid ADA was significantly higher in group I than group II (P1=0.000) and group III (P2=0.000). For diagnosing TB, CA125 showed a sensitivity and specificity of 74.1%, 76.9%, respectively while ADA demonstrated a sensitivity and specificity of 75% and 75% respectively.ConclusionCA-125 levels in pleural fluid may be used for differentiation between TB, pneumonic, and malignancy-induced effusions.Also CA125 may be added to the diagnostic workup of pleural fluid for accurate diagnosis of TB effusion